Paige Prostate

by Paige  · Based in United States → — AI to solve cancer’s most critical issuesRevolutionizing pathology with next generation technology
Oncology Pathology Urology

Subscription-based
Regulatory Status Disclosed

Overview

Paige Prostate is an AI-enabled digital pathology software suite designed to assist pathologists in the detection, grading, and quantification of prostate cancer. It is developed for use by pathologists in clinical laboratories, hospitals, and academic medical centers utilizing digital pathology workflows.

The software analyzes digitized, hematoxylin and eosin (H&E)-stained whole-slide images (WSIs) of formalin-fixed paraffin-embedded (FFPE) prostate needle biopsies. It integrates directly into the digital pathology workflow as an adjunctive, computer-assisted tool. After a pathologist completes their initial diagnostic review, the AI processes the slide. If it detects tissue morphology suspicious for cancer, it flags the slide and provides specific spatial coordinates (X,Y) pointing to the region with the highest likelihood of malignancy for further pathologist review.

Notable capabilities of the Paige Prostate Suite include:

  • Assisted Detection: Highlights suspicious foci to help pathologists identify subtle or small areas of concern.
  • Grading and Quantification: Assists in assessing tumor grade and volume to support diagnostic consistency.
  • Perineural Invasion (PNI) Detection: Identifies the presence of perineural invasion within tissue samples.
  • Workflow Efficiency: Serves as a digital “second set of eyes” to help reduce the need for routine immunohistochemistry (IHC) staining and expert consultations.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Assists in detecting prostate cancer (Paige Prostate Detect)
  • Grades and quantifies suspicious areas using Gleason scoring (Paige Prostate Grade & Quantify)
  • Identifies perineural invasion (Paige Prostate Perineural Invasion)
  • Detects biomarkers relevant to prostate cancer (Paige Prostate Biomarker Panel)
  • Works with H&E-stained whole-slide images (WSIs)
  • Highlights areas of suspicion for pathologist review
  • Cloud-based platform for data management and storage
  • Integrates with digital pathology platforms and various FDA-cleared scanners (e.g., Philips Ultra Fast Scanner)
  • Aims to improve diagnostic accuracy and efficiency
  • Aims to reduce false negatives and false positives

Use Cases

  • Assisting pathologists in the primary diagnosis of prostate cancer
  • Serving as a quality assurance tool to confirm pathology findings
  • Informing pathologist reviews in real-time
  • Streamlining diagnosis and accelerating digital pathology adoption
  • Reducing time spent on negative cases for pathologists
  • Improving consistency in tumor grading

What Physicians Need to Know

Key Capabilities
The Paige Prostate Suite aids in the detection and diagnosis of prostate cancer on H&E-stained whole-slide images of prostate needle biopsies. It is part of a broader suite of AI applications designed to support diagnostic decision-making in cancer pathology and can reveal multiple molecular biomarkers directly from tissue samples.
Clinical Utility
Developed to assist the diagnostic workflow in pathology, Paige's AI applications aim to alleviate time and resource pressures, enabling pathologists to better balance growing workloads while delivering informed, quality diagnoses. It provides a deep understanding of cancer’s molecular and cellular complexities for reliable detection and characterization.
Evidence Base
The Paige PanCancer Suite, which includes components relevant to prostate cancer, was developed using Virchow and cumulatively trained on over 1.5 million slides. Paige has exclusive access to millions of digitized pathology slides, clinical reports, and genomic data, leveraging 25 million accessible pathology slides, 350 thousand patients, and 200 thousand cases with outcome and genomic data.
Physician Tip

The Paige Prostate Suite is designed to be an AI-assisted tool, supporting pathologists in their diagnostic workflow for prostate cancer. It can help in identifying subtle complexities and molecular biomarkers from H&E-stained whole-slide images, potentially improving efficiency and diagnostic accuracy. Physicians should consider how this tool can integrate into existing pathology workflows to manage increasing caseloads and enhance diagnostic confidence.

While specific integration options for the Paige Prostate Suite are not detailed, Paige offers AI Technology & Services including foundation models and AI modules. They also provide comprehensive services for custom AI development, regulatory strategy, and commercialization, suggesting potential for integration into various digital pathology ecosystems or for developing customized AI models.

Details

Category Oncology AI, Pathology AI
Pricing Subscription-based
DeploymentCloud-based SaaS platform, integrates with existing digital pathology infrastructure.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated
Integrations
EHR Not specified
Specialties Oncology, Pathology, Urology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2021-09-21DEN200080 De NovoPaige Prostate

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Paige Prostate

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Paige Prostate.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

The Paige Prostate Suite offers comprehensive AI applications that aid in the detection and diagnosis of prostate cancer. It processes H&E-stained whole-slide images of prostate needle biopsies to support pathologists in their diagnostic decision-making.
Paige's AI applications, including those in the Paige Prostate Suite, are built off foundation model technology. The PanCancer Suite, which is related, was cumulatively trained on over 1.5 million slides, indicating a large dataset for development.
Yes, Paige's novel AI technologies, which include the Paige Prostate Suite, are capable of revealing multiple molecular biomarkers directly from the tissue sample, in addition to supporting diagnostic decision-making.
Paige Prostate is designed to assist the diagnostic workflow in pathology, aiming to alleviate time and resource pressures. This enables pathologists to better manage their workloads while continuing to deliver informed, quality diagnoses.
Yes, in addition to the Paige Prostate Suite, Paige offers the Paige Breast Suite for breast cancer, the Paige GI Suite for gastrointestinal tract conditions, and the Paige PanCancer Suite for identifying complexities in multiple tissue types, including rare cancers.

Related Tools

VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464)
Spectrum Dynamics Medical
Oncology AI
The VERITON CT 400 Series is a digital SPECT/CT system with a 360-degree gantry and 12 swiveling CZT detectors, offering high sensitivity and quantitative accuracy for a wide range of nuclear medicine applications, including advanced theranostics imaging.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
BIOGRAPH One
Siemens Healthineers AG
Oncology AI
BIOGRAPH One is a second-generation PET/MR scanner designed to transform PET/MR image quality for a new era, combining high PET precision with powerful MR performance. It enables simultaneous visualization of organ location, function, and cellular metabolism, offering faster image acquisition times and more efficient workflows than previous generations of PET/MR scanners.
Claire™ OCT System
Perimeter Medical Imaging AI
Oncology AI
Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultra-high resolution, real-time, advanced imaging tools that address unmet medical needs.S. for intraoperative breast cancer margin assessment.
syngo.via RT Image Suite VC10
Varian Medical Systems, Inc.
Clinical Decision Support & Reference
syngo.via RT Image Suite VC10 offers advanced imaging and workflow solutions for precise and efficient radiation therapy planning.

See all Oncology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-19 | First Added: 2026-04-21
AI Tool Finder
AI-powered search. Results may not be comprehensive.